Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 482

1.

Nitric oxide and oxidative stress in vascular disease.

Förstermann U.

Pflugers Arch. 2010 May;459(6):923-39. doi: 10.1007/s00424-010-0808-2. Epub 2010 Mar 21. Review.

PMID:
20306272
2.

Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies.

Förstermann U.

Nat Clin Pract Cardiovasc Med. 2008 Jun;5(6):338-49. doi: 10.1038/ncpcardio1211. Epub 2008 May 6. Review.

PMID:
18461048
3.

Vascular oxidative stress, nitric oxide and atherosclerosis.

Li H, Horke S, Förstermann U.

Atherosclerosis. 2014 Nov;237(1):208-19. doi: 10.1016/j.atherosclerosis.2014.09.001. Epub 2014 Sep 9. Review.

PMID:
25244505
4.

Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.

Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F.

Eur J Pharmacol. 2005 Mar 21;511(1):53-64.

PMID:
15777779
5.

Oxidative stress in vascular disease and its pharmacological prevention.

Li H, Horke S, Förstermann U.

Trends Pharmacol Sci. 2013 Jun;34(6):313-9. doi: 10.1016/j.tips.2013.03.007. Epub 2013 Apr 19. Review.

PMID:
23608227
6.

Vascular oxidative stress and nitric oxide depletion in HIV-1 transgenic rats are reversed by glutathione restoration.

Kline ER, Kleinhenz DJ, Liang B, Dikalov S, Guidot DM, Hart CM, Jones DP, Sutliff RL.

Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2792-804. doi: 10.1152/ajpheart.91447.2007. Epub 2008 May 2.

7.

Asymmetric dimethylarginine reduces nitric oxide donor-mediated dilation of arterioles by activating the vascular renin-angiotensin system and reactive oxygen species.

Veresh Z, Debreczeni B, Hamar J, Kaminski PM, Wolin MS, Koller A.

J Vasc Res. 2012;49(4):363-72. doi: 10.1159/000337485. Epub 2012 May 30.

8.

Nox4 NADPH oxidase mediates peroxynitrite-dependent uncoupling of endothelial nitric-oxide synthase and fibronectin expression in response to angiotensin II: role of mitochondrial reactive oxygen species.

Lee DY, Wauquier F, Eid AA, Roman LJ, Ghosh-Choudhury G, Khazim K, Block K, Gorin Y.

J Biol Chem. 2013 Oct 4;288(40):28668-86. doi: 10.1074/jbc.M113.470971. Epub 2013 Aug 12.

9.

Chronic hydrogen-rich saline treatment attenuates vascular dysfunction in spontaneous hypertensive rats.

Zheng H, Yu YS.

Biochem Pharmacol. 2012 May 1;83(9):1269-77. doi: 10.1016/j.bcp.2012.01.031. Epub 2012 Feb 9.

PMID:
22342731
10.

Is oxidative stress a therapeutic target in cardiovascular disease?

Münzel T, Gori T, Bruno RM, Taddei S.

Eur Heart J. 2010 Nov;31(22):2741-8. doi: 10.1093/eurheartj/ehq396. Epub 2010 Oct 25. Review.

PMID:
20974801
11.

Targeting NADPH oxidases in vascular pharmacology.

Schramm A, Matusik P, Osmenda G, Guzik TJ.

Vascul Pharmacol. 2012 May-Jun;56(5-6):216-31. doi: 10.1016/j.vph.2012.02.012. Epub 2012 Mar 3. Review.

12.

Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities.

Thomas SR, Witting PK, Drummond GR.

Antioxid Redox Signal. 2008 Oct;10(10):1713-65. doi: 10.1089/ars.2008.2027. Review.

PMID:
18707220
13.

Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.

Suda O, Tsutsui M, Morishita T, Tasaki H, Ueno S, Nakata S, Tsujimoto T, Toyohira Y, Hayashida Y, Sasaguri Y, Ueta Y, Nakashima Y, Yanagihara N.

Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1682-8. Epub 2004 Jun 24.

PMID:
15217805
14.

Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension.

Schulz E, Jansen T, Wenzel P, Daiber A, Münzel T.

Antioxid Redox Signal. 2008 Jun;10(6):1115-26. doi: 10.1089/ars.2007.1989. Review.

PMID:
18321209
15.

Resveratrol Protects against Titanium Particle-Induced Aseptic Loosening Through Reduction of Oxidative Stress and Inactivation of NF-κB.

Luo G, Li Z, Wang Y, Wang H, Zhang Z, Chen W, Zhang Y, Xiao Y, Li C, Guo Y, Sheng P.

Inflammation. 2016 Apr;39(2):775-85. doi: 10.1007/s10753-016-0306-6.

PMID:
26878849
16.

Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-Glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan.

Knorr M, Hausding M, Kröller-Schuhmacher S, Steven S, Oelze M, Heeren T, Scholz A, Gori T, Wenzel P, Schulz E, Daiber A, Münzel T.

Arterioscler Thromb Vasc Biol. 2011 Oct;31(10):2223-31. doi: 10.1161/ATVBAHA.111.232058. Epub 2011 Jul 14.

PMID:
21757654
17.

Oxidative stress and endothelial dysfunction: clinical evidence and therapeutic implications.

Higashi Y, Maruhashi T, Noma K, Kihara Y.

Trends Cardiovasc Med. 2014 May;24(4):165-9. doi: 10.1016/j.tcm.2013.12.001. Epub 2013 Dec 4. Review.

PMID:
24373981
18.

The renoprotective effect of L-carnitine in hypertensive rats is mediated by modulation of oxidative stress-related gene expression.

Zambrano S, Blanca AJ, Ruiz-Armenta MV, Miguel-Carrasco JL, Revilla E, Santa-María C, Mate A, Vázquez CM.

Eur J Nutr. 2013 Sep;52(6):1649-59. doi: 10.1007/s00394-012-0470-x. Epub 2012 Dec 6.

PMID:
23223967
19.

Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress.

Briones AM, Rodríguez-Criado N, Hernanz R, García-Redondo AB, Rodrigues-Díez RR, Alonso MJ, Egido J, Ruiz-Ortega M, Salaices M.

Hypertension. 2009 Jul;54(1):142-9. doi: 10.1161/HYPERTENSIONAHA.109.133710. Epub 2009 May 18.

PMID:
19451411
20.

Mechanisms of vascular dysfunction in mice with endothelium-specific deletion of the PPAR-δ gene.

d'Uscio LV, He T, Santhanam AV, Tai LJ, Evans RM, Katusic ZS.

Am J Physiol Heart Circ Physiol. 2014 Apr 1;306(7):H1001-10. doi: 10.1152/ajpheart.00761.2013. Epub 2014 Jan 31.

Supplemental Content

Support Center